Literature DB >> 16691534

Increased collagen deposition correlated with lung destruction in human emphysema.

C Martin-Mosquero1, G Peces-Barba, M L Rubio, M Ortega, M J Rodriguez-Nieto, L Martinez Galan, N Gonzalez-Mangado.   

Abstract

BACKGROUND: To study the relationship between collagen amount and degree of emphysema as assessed by mean linear intercept (Lm) and correlating these with lung function test workup in patients with and without COPD.
METHODS: Lung function tests were assessed in 16 smokers or ex-smokers and 1 non-smoker in order to separate them into two groups: COPD (FEV1/FVC lower than 70%) and non-COPD. A piece of lung tissue was used to analyse the collagen amount (HYP) by means of a colorimetric method. Morphometry was assessed to divide patients into two groups according to Lm: Lm > 260 micrometers was considered non-emphysema and Lm < 260 mm mild-emphysema.
RESULTS: The non-emphysema group had a mean Lm value of 246.08+/-3.12 micrometers and the mild-emphysema group of 276.29+/-4.26 micrometers. The amount of hydroxyproline was significantly higher in the mild-emphysema group than in the non-emphysema group (7.82+/-0.67 vs. 5.50+/-0.54 microgram/g tissue). There was a clear positive correlation between Lm and HYP (r=0.55) and a negative correlation between Lm and DlCO (R=-0.5092). No correlation was found between the functional test and HYP, nor were there significant differences between COPD and non-COPD patients for Lm and HYP.
CONCLUSIONS: Emphysema is associated with collagen deposition in the lungs, and air space size correlates with the amount of lung collagen even when there is no emphysema.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16691534     DOI: 10.14670/HH-21.823

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

1.  Loss of core-fucosylation of SPARC impairs collagen binding and contributes to COPD.

Authors:  Tsai-Jung Wu; Sheng-Hung Wang; Eric Sheng-Wen Chen; Hsiu-Hui Tsai; Yi-Chieh Chang; Yi-Hsin Tseng; John Yu
Journal:  Cell Mol Life Sci       Date:  2022-06-07       Impact factor: 9.207

Review 2.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

Review 3.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

4.  Chronic LPS inhalation causes emphysema-like changes in mouse lung that are associated with apoptosis.

Authors:  David M Brass; John W Hollingsworth; Mark Cinque; Zhouwei Li; Erin Potts; Eric Toloza; William M Foster; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-06       Impact factor: 6.914

5.  Moderate Aerobic Training Improves Cardiorespiratory Parameters in Elastase-Induced Emphysema.

Authors:  Isabela Henriques; Miquéias Lopes-Pacheco; Gisele A Padilha; Patrícia S Marques; Raquel F Magalhães; Mariana A Antunes; Marcelo M Morales; Nazareth N Rocha; Pedro L Silva; Débora G Xisto; Patricia R M Rocco
Journal:  Front Physiol       Date:  2016-08-03       Impact factor: 4.566

6.  (-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats.

Authors:  Yingmin Liang; Kenneth W K Liu; Sze C Yeung; Xiang Li; Mary S M Ip; Judith C W Mak
Journal:  Front Pharmacol       Date:  2017-09-06       Impact factor: 5.810

7.  Enhancing tristetraprolin activity reduces the severity of cigarette smoke-induced experimental chronic obstructive pulmonary disease.

Authors:  Prema M Nair; Malcolm R Starkey; Tatt Jhong Haw; Gang Liu; Adam M Collison; Joerg Mattes; Peter A Wark; Jonathan C Morris; Nikki M Verrills; Andrew R Clark; Alaina J Ammit; Philip M Hansbro
Journal:  Clin Transl Immunology       Date:  2019-10-28

Review 8.  Future therapeutic treatment of COPD: struggle between oxidants and cytokines.

Authors:  Willem I de Boer; Hongwei Yao; Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.